H5N1 Viruses and Vaccines

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2007 Mar 6

PMID 17335350

Citations 23

Authors

Kanta Subbarao

Catherine Luke

Affiliations

Soon will be listed here.

Citing Articles

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith G, Sun X, Bai Y, Liu Y, Massare M, Pearce M Virology. 2017; 509:90-97.

PMID: 28624679 PMC: 5788299. DOI: 10.1016/j.virol.2017.06.006.

A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

Liu F, Sun X, Fairman J, Lewis D, Katz J, Levine M Virology. 2016; 492:197-203.

PMID: 26967975 PMC: 5796654. DOI: 10.1016/j.virol.2016.02.024.

Ferret models of viral pathogenesis.

Enkirch T, von Messling V Virology. 2015; 479-480:259-70.

PMID: 25816764 PMC: 7111696. DOI: 10.1016/j.virol.2015.03.017.

Animal models for influenza virus pathogenesis, transmission, and immunology.

Thangavel R, Bouvier N J Immunol Methods. 2014; 410:60-79.

PMID: 24709389 PMC: 4163064. DOI: 10.1016/j.jim.2014.03.023.

Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Govorkova E, Baranovich T, Seiler P, Armstrong J, Burnham A, Guan Y Antiviral Res. 2013; 98(2):297-304.

PMID: 23458714 PMC: 3648604. DOI: 10.1016/j.antiviral.2013.02.013.

References

Qiao C, Yu K, Jiang Y, Jia Y, Tian G, Liu M . Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 2003; 32(1):25-32. DOI: 10.1080/0307945021000070688. View

Gao W, Soloff A, Lu X, Montecalvo A, Nguyen D, Matsuoka Y . Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol. 2006; 80(4):1959-64. PMC: 1367171. DOI: 10.1128/JVI.80.4.1959-1964.2006. View

Wright P, Dolin R, La Montagne J . From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. J Infect Dis. 1976; 134(6):633-8. DOI: 10.1093/infdis/134.6.633. View

Wright P, Thompson J, Vaughn W, Folland D, SELL S, Karzon D . Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis. 1977; 136 Suppl:S731-41. DOI: 10.1093/infdis/136.supplement_3.s731. View

Kodihalli S, Goto H, Kobasa D, Krauss S, Kawaoka Y, Webster R . DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol. 1999; 73(3):2094-8. PMC: 104453. DOI: 10.1128/JVI.73.3.2094-2098.1999. View

Li S, Liu C, Klimov A, Subbarao K, Perdue M, Mo D . Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis. 1999; 179(5):1132-8. DOI: 10.1086/314713. View

Rimmelzwaan G, Claas E, van Amerongen G, de Jong J, Osterhaus A . ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine. 1999; 17(11-12):1355-8. DOI: 10.1016/s0264-410x(98)00390-9. View

Lu X, Tumpey T, Morken T, Zaki S, Cox N, Katz J . A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol. 1999; 73(7):5903-11. PMC: 112651. DOI: 10.1128/JVI.73.7.5903-5911.1999. View

Takada A, KUBOKI N, Okazaki K, Ninomiya A, Tanaka H, Ozaki H . Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. J Virol. 1999; 73(10):8303-7. PMC: 112847. DOI: 10.1128/JVI.73.10.8303-8307.1999. View

10.

Ungchusak K, Auewarakul P, Dowell S, Kitphati R, Auwanit W, Puthavathana P . Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005; 352(4):333-40. DOI: 10.1056/NEJMoa044021. View

11.

Hoelscher M, Garg S, Bangari D, Belser J, Lu X, Stephenson I . Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet. 2006; 367(9509):475-81. PMC: 2762105. DOI: 10.1016/S0140-6736(06)68076-8. View

12.

Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S . The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine. 2005; 24(17):3669-76. DOI: 10.1016/j.vaccine.2005.07.005. View

13.

Treanor J, Campbell J, Zangwill K, Rowe T, Wolff M . Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006; 354(13):1343-51. DOI: 10.1056/NEJMoa055778. View

14.

Bresson J, Perronne C, Launay O, Gerdil C, Saville M, Wood J . Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet. 2006; 367(9523):1657-64. DOI: 10.1016/S0140-6736(06)68656-X. View

15.

Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, Starick E . Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A. 2006; 103(21):8197-202. PMC: 1472452. DOI: 10.1073/pnas.0602461103. View

16.

Govorkova E, Webby R, Humberd J, Seiler J, Webster R . Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis. 2006; 194(2):159-67. DOI: 10.1086/505225. View

17.

Maines T, Chen L, Matsuoka Y, Chen H, Rowe T, Ortin J . Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A. 2006; 103(32):12121-6. PMC: 1567706. DOI: 10.1073/pnas.0605134103. View

18.

Lin J, Zhang J, Dong X, Fang H, Chen J, Su N . Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet. 2006; 368(9540):991-7. DOI: 10.1016/S0140-6736(06)69294-5. View

19.

Lipatov A, Hoffmann E, Salomon R, Yen H, Webster R . Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis. 2006; 194(8):1040-3. DOI: 10.1086/507709. View

20.

Lu X, Edwards L, Desheva J, Nguyen D, Rekstin A, Stephenson I . Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine. 2006; 24(44-46):6588-93. DOI: 10.1016/j.vaccine.2006.05.039. View